SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-001554 from BIOLASE, INC (BIOL) (CIK 0000811240)

BIOLASE, INC (BIOL) (CIK 0000811240)
Date: Jan. 4, 2023 · CIK: 0000811240 · Accession: 0001193125-23-001554

AI Filing Summary & Sentiment

File numbers found in text: 333-268528

Date
January 4, 2023
Author
LAKE STREET CAPITAL MARKETS, LLC
Form
CORRESP
Company
BIOLASE, INC (BIOL) (CIK 0000811240)

Letter

Re: Biolase, Inc.

January 4, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1, as amended

File No. 333-268528

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), Lake Street Capital Markets, LLC, as the representative of the several underwriters, hereby joins in the request of Biolase, Inc. for acceleration of the effective date of the above-referenced registration statement on Form S-1, as amended (the “Registration Statement”), so that it becomes effective as of 5:00 p.m. Eastern Time on Thursday, January 5, 2023, or as soon thereafter as possible.

Pursuant to Rule 460 of the General Rules and Regulations of the Securities Act, we wish to advise you that we have distributed approximately 500 copies of the preliminary prospectus to prospective underwriters, institutional investors, dealers and others.

The undersigned has and will comply, and it has been informed or will be informed by any participating dealers that they have complied or will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature Page to Follow]

Very truly yours,
LAKE STREET CAPITAL MARKETS, LLC

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 January 4, 2023

VIA EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

Washington, D.C. 20549

Re:
 Biolase, Inc.

Registration Statement on Form S-1, as amended

File No. 333-268528

Request for Acceleration of Effective Date

Ladies and Gentlemen:

 Pursuant to Rule 461 of the General
Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), Lake Street Capital Markets, LLC, as the representative of the several underwriters, hereby joins in the request of Biolase, Inc. for
acceleration of the effective date of the above-referenced registration statement on Form S-1, as amended (the “Registration Statement”), so that it becomes effective as of 5:00
p.m. Eastern Time on Thursday, January 5, 2023, or as soon thereafter as possible.

 Pursuant to Rule 460 of the General Rules and Regulations of
the Securities Act, we wish to advise you that we have distributed approximately 500 copies of the preliminary prospectus to prospective underwriters, institutional investors, dealers and others.

The undersigned has and will comply, and it has been informed or will be informed by any participating dealers that they have complied or will comply, with
the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature Page to Follow]

Very truly yours,

LAKE STREET CAPITAL MARKETS, LLC

As Representative of the Several Underwriters

Named in the Underwriting Agreement

By:

 /s/ Michael Townley

Name: Michael Townley

Title: Head of Investment Banking

 [Signature Page to Underwriters’ Acceleration Request]